drugset / Trial / NCT02678416

Reduction in Pain Intensity Following IV or Oral Pain-relieving Products

NCT02678416 ↗

Phase 4 Completed 79 enrolled Mallinckrodt
RandomizedCrossoverDouble-blindOther

Summary

The purpose of this study is to evaluate two experimental pain models to see if they would be useful for comparing different products for reduction in pain intensity. The models evaluated were the ultraviolet-B (UVB) burn and intradermal capsaicin experimental pain models. Medications compared were a single dose each, of intravenous (IV) acetaminophen, oral acetaminophen, placebo, and IV morphine.

Timeline

Start
2015-12-07
Primary completion
2016-06-13
Completion
2016-06-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule — Intravenous

Indications

No indication recorded.